Drug intelligence / Profile preview

Strontium chloride

Development stage
Phase 4
Lead developer
Q BioMed
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Strontium chloride is a salt of strontium and chlorine that exists in both non-radioactive (SrCl2) and radioactive forms (notably Strontium-89 Chloride). The radioactive form (strontium-89 chloride) is used as a radiopharmaceutical agent for the relief of bone pain associated with skeletal metastases from cancers such as prostate and breast cancer. After intravenous injection, it behaves similarly to calcium by localizing in areas of active bone formation—especially metastatic lesions—where it emits beta radiation that helps reduce pain and may have tumoricidal effects. Non-radioactive formulations were previously used in toothpaste for dentin hypersensitivity but are now largely obsolete[1][2][3][4][5].

Brand names
Metastron
Other names
SrCl2SrCl-2SrCl 2strontium-89 chloridestrontium89 chloridestrontium 89 chloridestrontium chloride Sr-89

Beyond the preview

Go deeper on Strontium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Strontium chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call